SCHEMBL24253389

SCHEMBL24253389

CC(N)c1cc[nH]c(=O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 1/20 0.42
GRM4 Q14833 1/20 0.42
GABRP O00591 2/20 0.39
GABRD O14764 2/20 0.39
GABRA1 P14867 2/20 0.39
GABRB1 P18505 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRA3 P34903 2/20 0.39
GABRA2 P47869 2/20 0.39
GABRB2 P47870 2/20 0.39
GABRA4 P48169 2/20 0.39
GABRE P78334 2/20 0.39
GABRA6 Q16445 2/20 0.39
GABRG1 Q8N1C3 2/20 0.39
GABRG3 Q99928 2/20 0.39
GABRQ Q9UN88 2/20 0.39
NOTUM Q6P988 1/20 0.39
ADRB2 P07550 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1104783 0.83 NOTUM (0.42) GRM8GRM4NOTUMFKBP5HDAC6
SCHEMBL28018145 0.79 NOTUM (0.39) GRM8GRM4NOTUMFKBP5MAP4K4
SCHEMBL19441070 0.79 NOTUM (0.39) GRM8GRM4NOTUMFKBP5HDAC6
SCHEMBL28265713 0.78 HDAC6 (0.45) GRM8GRM4NOTUMFKBP5HDAC6
SCHEMBL19365913 0.76 HDAC4 (0.46) GRM8GRM4NOTUMFKBP5NSD2
SCHEMBL18474686 0.73 GRM8 (0.39) GRM8GRM4NOTUMNSD2ABL1
SCHEMBL27377916 0.71 NOTUM (0.37) GRM8GRM4NOTUMSMYD3PTGS2
SCHEMBL6989796 0.71 PNMT (0.46)
SCHEMBL13741453 0.69 PTGS2 (0.43) GRM8GRM4NOTUML3MBTL1PTGS2
SCHEMBL25064753 0.68 GRM8 (0.38) GRM8GRM4NOTUMNSD2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048890-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048890-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SF3B5 GRM8 2304/4885GRM4 2812/4885GABRP 1886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.